Analyst Research

Report Title Price
Provider: GlobalData
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ranbaxy Laboratories Ltd To Pay $500 Million In US Settlement-Reuters

Monday, 13 May 2013 05:39pm EDT 

Reuters reported that Ranbaxy Laboratories Ltd pleaded guilty to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the U.S. Department of Justice. It includes $150 million in payments for a criminal fine and forfeiture and $350 million in payments for civil claims. 

Company Quote

8.85 +1.46%
26 Dec 2014